Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...

Bengaluru led with 22.1 msf, nearly one-third of demand, while Delhi NCR, Hyderabad, Chennai and Mumbai each recorded about 10 msf, or a 13–16% share | ...

The Fund outperformed its benchmark with a 1.39% return as the Fed initiated an easing cycle. Read the full commentary to ...

The cyclone affected nearly 2 million people and more than 500,000 families across all 25 districts, disrupting livelihoods, ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

CoinEx's 2025 annual report highlights a profound structural shift in the cryptocurrency market. The traditional '4-Year ...